Buy Biocon Limited:
Biocon Ltd has officially announced a consolidated sales of Rs. 1,851.00 Cr for the third quarter finished on 31-12-2020, which is 6.09% up from its previous quarter sales of Rs. 1,744.80 Cr and 5.89% up from its previous year same quarter sales of Rs. 1,748.10 Cr. The company has reported net profit after tax of Rs. 187.40 Cr in the previous quarter.
Outlook:
Biocon Ltd: Experts suggested buy call at current market price: Rs. 379.65 with a target price: Rs. 389; Stoploss: Rs. 374.
Buy Dr. Reddy’s Laboratories Limited:
Dr. Reddy’s Laboratories Ltd has officially announced a consolidated sales of Rs. 4,896.70 Cr for the third quarter finished on 30-09-2020, which is 10.85% up from its previous quarter sales of Rs. 4,417.50 Cr and 2.00% up from its previous year same quarter sales of Rs. 4,800.80 Cr. The company has reported a net profit after tax of Rs. 764.50 Cr in the previous quarter.
Outlook:
Dr. Reddy’s Laboratories Ltd: Experts suggested buy call at current market price: Rs. 5,163.10 with a target price: Rs. 5,200; Stoploss: Rs. 5,150.
Disclaimer: The perspectives and investment tips are given in this section are the expert’s own and not that of the website or its management. We encourage clients to check with certified experts before taking any position in the stocks/shares mentioned.